S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

NCT00243074 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Mesothelioma
Epithelial Mesothelioma
Recurrent Malignant Mesothelioma
Sarcomatous Mesothelioma

Interventions

DRUG: cediranib maleate
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)